Hillary K. Grigonis is a tech writer, photographer, and licensed drone pilot. With over a decade of experience geeking out over the latest tech, she's an expert in cameras, drones, computing, and ...
TG Therapeutics Inc. (NASDAQ:TGTX) shares advanced Wednesday after the biopharmaceutical company announced the completion of a $100 million share repurchase program and unveiled plans for an ...
A huge miss on the bottom line drove investors away from the shares. Yet sales of the company's one commercialized medicine have been brisk. The company, best known for its multiple sclerosis (MS) ...
Approved in February of 2021, TG Therapeutics’ first-in-class drug Ukoniq was billed as a potentially safer treatment for lymphoma patients. But 16 months later, the FDA has rescinded its approval of ...
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback